Box score
Immunovant, Inc.
Reported $450M sold in a new Form D filed January 21, 2025 (New York, New York).
- Biggest raise
- $450M filed Jan 21, 2025
- League
- Bio & Health Pharmaceuticals
- Based in
- New York, New York
- Season rank
- #2 of 1,311 in the Bio & Health League; #32 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-01-21 | New notice | $450M | $450M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1764013.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Sharps Technology Inc. | Bio & Health | $411M |
| 2 | ByHeart, Inc. | Bio & Health | $72.2M |
| 3 | Applied Dna Sciences Inc | Bio & Health | $58M |
| 4 | Diana Health, Inc. | Bio & Health | $55.4M |
| 5 | Click Therapeutics, Inc. | Bio & Health | $48.6M |
| 6 | Iantrek, Inc. | Bio & Health | $34.7M |